Despite no significant correlation of increased HAS3 expression with reduced patient clinical outcome or with any clinicopathologic characteristic, a concordant increase of both TNF-α and HAS3 expression not only was associated with lymph node metastasis but also further reduced overall survival among late-stage oral cancer patients. The gene discussed is TNF; the disease is metastatic malignant neoplasm in the lymph nodes.